General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Cordis(MODEST) SPEAKER'S BUREAU: Jannsen Pharmaceuticals(SIGNIFICANT), Terumo(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Frond Medical(SIGNIFICANT)

View Full Disclosure